miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells

Area of Science:

• Molecular Biology
• Immunology

Background:

• MicroRNAs (miRNAs) like miR-19a and miR-20a regulate gene expression post-transcriptionally.
• Tissue Factor (TF) plays a crucial role in hemostasis and inflammation.
• Dysregulation of miRNAs and TF is implicated in various pathological conditions.

Purpose of the Study:

• To investigate the behavior of miR-19a and miR-20a in peripheral blood mononuclear cells (PBMCs) under high glucose (HG) and lipopolysaccharide (LPS) conditions.
• To assess the role of angiotensin II in modulating TF expression and miRNA levels during inflammation.

Main Methods:

• PBMCs were exposed to high glucose (50 mM), LPS (100 ng/mL), and Olmesartan (10^-6 M), an angiotensin II receptor blocker.
• TF Procoagulant Activity (PCA) and antigen (Ag) levels were measured using clotting assays and ELISA.
• miR-19a and miR-20a levels were quantified using TaqMan® MicroRNA Assays.

Main Results:

• High glucose significantly increased TF expression and decreased miR-19a and miR-20a levels compared to normal glucose conditions.
• In HG-exposed PBMCs, LPS further stimulated TF expression and downregulated miR-20a.
• Olmesartan treatment reverted the LPS-induced downregulation of miR-20a in HG conditions, while miR-19a levels remained unaffected by LPS.

Conclusions:

• miR-19a and miR-20a are differentially regulated by inflammatory stimuli affecting TF expression.
• Angiotensin II signaling appears to be involved in the inflammatory modulation of these miRNAs and TF expression.